Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.

Collins MG, Fahim MA, Pascoe EM, Dansie KB, Hawley CM, Clayton PA, Howard K, Johnson DW, McArthur CJ, McConnochie RC, Mount PF, Reidlinger D, Robison L, Varghese J, Vergara LA, Weinberg L, Chadban SJ, BEST-Fluids Investigators and the Australasian Kidney Trials Network

Open source

DOI: 10.1186/s13063-020-04359-2
Published: 2020 May 25
Container: Trials
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-020-04359-2,
  title = {Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9\% saline on delayed graft function in deceased donor kidney transplantation.},
  author = {Collins MG and Fahim MA and Pascoe EM and Dansie KB and Hawley CM and Clayton PA and Howard K and Johnson DW and McArthur CJ and McConnochie RC and Mount PF and Reidlinger D and Robison L and Varghese J and Vergara LA and Weinberg L and Chadban SJ and BEST-Fluids Investigators and the Australasian Kidney Trials Network},
  year = {2020},
  journal = {Trials},
  doi = {10.1186/s13063-020-04359-2},
  url = {https://doi.org/10.1186/s13063-020-04359-2}
}

RIS

TY  - JOUR
TI  - Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
AU  - Collins MG
AU  - Fahim MA
AU  - Pascoe EM
AU  - Dansie KB
AU  - Hawley CM
AU  - Clayton PA
AU  - Howard K
AU  - Johnson DW
AU  - McArthur CJ
AU  - McConnochie RC
AU  - Mount PF
AU  - Reidlinger D
AU  - Robison L
AU  - Varghese J
AU  - Vergara LA
AU  - Weinberg L
AU  - Chadban SJ
AU  - BEST-Fluids Investigators and the Australasian Kidney Trials Network
PY  - 2020
JO  - Trials
DO  - 10.1186/s13063-020-04359-2
UR  - https://doi.org/10.1186/s13063-020-04359-2
ER  -

APA

MG, C., MA, F., EM, P., KB, D., CM, H., PA, C., K, H., DW, J., CJ, M., RC, M., PF, M., D, R., L, R., J, V., LA, V., L, W., SJ, C., & Network, B. I. A. T. A. K. T. (2020). Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.. Trials. https://doi.org/10.1186/s13063-020-04359-2

Source records

pubmed · retrieved 2026-09-26T06:28:06.380Z